Search results
FDA Approves Rystiggo: The Only Treatment for Two Most Common Subtypes of Generalized Myasthenia...
Benzinga via Yahoo Finance· 10 months agoThe FDA approved UCB SA's (OTC: UCBJF) (OTC: UCBJY) Rystiggo (rozanolixizumab-noli) for generalized...
What Is Myasthenia Gravis?
Health via Yahoo News· 11 months agoMyasthenia gravis (MG) is a chronic (long-term) autoimmune disorder that causes muscle weakness and fatigue. When a person has an autoimmune disorder,...
Decoding Anticholinergic Drugs: Uses, Safety, and More
Verywell Health via Yahoo News· 4 months agoFor Medical Conditions Relating to the Bladder, Digestive System, Brain, and More Medically reviewed...
Anti-Nausea Medicine: What Products Should I Use?
Verywell Health via Yahoo News· 8 months agoNausea is an uncomfortable or “queasy” feeling with or without the urge to vomit. How to treat nausea can be determined by its cause. Both...
Europe's CHMP Recommends Approving AstraZeneca's Asthma, Neuromuscular Disorder Treatments
Benzinga via Yahoo Finance· 2 years agoThe European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has...
AstraZeneca's (AZN) Ultomiris Gets EC Nod for New Indication
Zacks via Yahoo Finance· 2 years agoAstraZeneca AZN announced that the European Commission has granted marketing approval to long-acting...
Argenx's Vyvgart Hytrulo Becomes First FDA Approved Subcutaneous Option For Generalized Myasthenia...
Benzinga via Yahoo Finance· 10 months agoThe FDA has approved Argenx SE's (NASDAQ: ARGX) Vyvgart Hytrulo (efgartigimod alfa and...
Argenx's Drug Scores European Approval For Muscular Fatigue Disorder
Benzinga via Yahoo Finance· 2 years agoThe European Commission has approved Argenx SE's (NASDAQ: ARGX) Vyvgart (efgartigimod alfa-fcab) as...
Novartis' (NVS) PNH Candidate Achieves Study Objectives
Zacks via Yahoo Finance· 1 year agoNovartis' (NVS) phase III study APPOINT-PNH evaluating investigational oral monotherapy iptacopan in...
Back-To-Back Three Japanese Approvals For AstraZeneca's Rare Disease Treatments
Benzinga via Yahoo Finance· 2 years agoThe Japan regulatory authority has approved AstraZeneca Plc (NASDAQ: AZN) and Merck Co Inc's (NYSE:...
